Chronic Kidney Disease: Filtration Markers Beyond Creatinine

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Blood testing for CKD uses six markers—creatinine, eGFR, BUN, albumin, corrected calcium, and potassium—to detect early signs of reduced filtration, protein loss, and mineral-electrolyte imbalances. A persistent eGFR below 60 or rising creatinine suggests chronic impairment, while abnormal potassium is associated with dangerous arrhythmias. Tracking this panel links kidney function to cardiovascular risk, bone integrity, and nerve health.

Read more →

Understand what your kidney function testing results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Chronic kidney disease and the markers that trace filtration

Chronic kidney disease biomarkers are the body’s chemical signals that show how well the kidneys are filtering, balancing, and adapting under stress. Blood tests turn invisible kidney work into clear indicators: waste removal (creatinine; cystatin C), protein breakdown handling (urea nitrogen), salt and acid–base balance (potassium; bicarbonate), mineral and bone regulation (phosphate; calcium; parathyroid hormone), and red blood cell support (hemoglobin, reflecting erythropoietin activity). From these values, clinicians estimate overall filtering capacity (estimated glomerular filtration rate, eGFR), which summarizes how efficiently blood is being cleaned. Together, these biomarkers detect kidney stress early—often before symptoms—track changes over time, and reveal downstream effects that matter for daily health, like heart rhythm stability, bone strength, and energy levels. They also guide safe medication choices and dosing, since many drugs rely on kidney clearance. In short, CKD biomarkers provide a continuous readout of filtration, damage, and compensation, allowing timely action to protect kidney function and the systems the kidneys support.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why CKD bloodwork connects to more than the kidneys

Chronic kidney disease testing looks at how well your kidneys filter, balance fluids and electrolytes, manage acid–base, and support bones, blood vessels, and nerves. Because kidneys sit at the crossroads of waste removal, hormone signaling, and mineral metabolism, their biomarkers reflect whole‑body health long before symptoms are obvious. Creatinine typically sits around 0.6–1.3, with men higher than women due to muscle mass; within normal, lower tends to reflect better filtration. eGFR is best high (near or above 90), and a persistent value under 60 suggests chronic impairment. BUN is most reassuring mid‑range, roughly 7–20. Serum albumin is healthiest in the mid‑to‑high normal band, about 3.5–5.0. Corrected calcium is most stable in the middle, near 8.6–10.2. Potassium is safest in the middle, about 3.5–5.0. When these numbers fall, they tell different stories. A low creatinine often reflects low muscle mass or pregnancy’s higher filtration; in older adults and women, baseline runs lower. A low eGFR signals reduced nephron function and may bring fatigue, swelling, or rising blood pressure. Low BUN can reflect low protein intake or liver dysfunction. Low albumin points to inflammation, malnutrition, or urinary protein loss, with edema and frailty. Low corrected calcium in CKD stems from disordered vitamin D–phosphate balance, causing cramps, tingling, or brittle bones. Low potassium can trigger weakness or heart rhythm problems. Conversely, rising creatinine with falling eGFR indicates accumulating wastes; BUN may climb with nausea, itch, or mental fog. High potassium risks dangerous arrhythmias. Calcium can run high with advanced parathyroid overactivity. Even with normal serum albumin, increased urinary albumin is an early vascular–kidney warning. Big picture, these tests link kidney filtration to cardiovascular risk, bone integrity, nerve and muscle function, and long‑term outcomes like heart events, fractures, and hospitalization.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

What a CKD blood panel captures and what it misses

Chronic kidney disease (CKD) blood testing provides a window into how well your kidneys are supporting the body’s essential systems. Healthy kidneys filter waste, balance fluids and electrolytes, regulate blood pressure, and help maintain bone and cardiovascular health. When kidney function declines, it can disrupt energy production, metabolism, cognition, immunity, and reproductive health. At Superpower, we assess CKD risk and status using creatinine, estimated glomerular filtration rate (eGFR), blood urea nitrogen (BUN), albumin, corrected calcium, and potassium. Creatinine is a waste product from muscle metabolism, and its blood level rises when kidney filtration slows. eGFR is a calculated estimate of how efficiently your kidneys filter blood, with lower values indicating reduced function. BUN reflects the amount of nitrogen in your blood from urea, another waste product; elevated BUN can signal impaired kidney clearance. Albumin is a major blood protein made by the liver; low levels may suggest kidney leakage or other systemic issues. Corrected calcium accounts for albumin levels to give a more accurate picture of calcium status, which is tightly regulated by the kidneys. Potassium is a key electrolyte for nerve and muscle function, and abnormal levels can result from impaired kidney excretion. Together, these biomarkers reveal how stable and effective your kidneys are at maintaining internal balance. Changes in these values can indicate early or advanced CKD, affecting the body’s ability to manage waste, fluid, and mineral balance. Interpretation of CKD biomarkers can be influenced by age, pregnancy, acute illness, certain medications, and laboratory methods. These factors should be considered when evaluating results.

Frequently Asked Questions

References

  1. Chen TK, Knicely DH, Grams ME (2019). Chronic kidney disease diagnosis and management: a review. *JAMA*, *322*(13), 1294-1304. https://doi.org/10.1001/jama.2019.14745
  2. Levey AS, Becker C, Inker LA (2015). Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. *JAMA*, *313*(8), 837-846. https://doi.org/10.1001/jama.2015.0602
  3. Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT (2013). Cystatin C versus creatinine in determining risk based on kidney function. *The New England Journal of Medicine*, *369*(10), 932-943. https://doi.org/10.1056/nejmoa1214234
  4. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS (2007). Prevalence of chronic kidney disease in the United States. *JAMA*, *298*(17), 2038-2047. https://doi.org/10.1001/jama.298.17.2038
  5. Glassock RJ, Warnock DG, Delanaye P (2017). The global burden of chronic kidney disease: estimates, variability and pitfalls. *Nature Reviews Nephrology*, *13*(2), 104-114. https://doi.org/10.1038/nrneph.2016.163

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey